tirzepatide breastfeeding data Is Safe While Breastfeeding? FDA Guidance & Alternatives Alexandra Sowa, MD | A

it's a foundational part of how we manage our health

Exercise is what determines whether you lose fat or just weight

your genes play a significant role in how your body absorbs, metabolizes, and responds to GLP-1 therapy

Pediatric Oncall Drug Database

SURPASS-4, a multicenter open-label RCT comparing treatment with tirzepatide and insulin glargine in T2D patients at increased CV risk for a median of 85 weeks, was the only study in the SURPASS program to include the change from baseline in eGFR and UACR and occurrence of eGFR decline of at least 40%, renal death, progression to end-stage kidney disease or new-onset MA among the prespecified analyses [48]